Fig. 1 · Structure
Documents & Downloads
DC-015
Alpha 1-adrenoceptor Antagonist
DC-015 is a selective and orally active alpha 1-adrenoceptor antagonist. This synthesized quinazoline derivative exhibits significant antihypertensive activity by decreasing mean arterial pressure in a hyperlipidaemic rodent model. DC-015's effects on plasma lipid levels and vascular reactivity make it a valuable tool for studying cardiovascular conditions and related research applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 149847-87-0 |
| Applications | Alpha 1-adrenoceptor Antagonist |
| Formula | C22H25N5O2 |
| Molecular Weight | 391.47 |
| SMILES | O=C1NC2=C(C=CC=C2)C3=NCC(CN4CCN(C5=CC=CC=C5OC)CC4)N13 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.